Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330278 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330279 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330282 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330291 (1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330288 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 68 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330283 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 77 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330275 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 83 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330264 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 98 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330285 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 105 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330289 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 118 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330272 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 119 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330276 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 133 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330266 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 151 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330273 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 155 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330263 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 161 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330264 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 161 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330260 (1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 164 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330262 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 165 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330270 (1-(3-(tert-butyl)-1-(p-tolyl)-lH-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 169 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330265 (1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330260 (1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 171 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330261 (1-(3-(tert-butyl)-1-(4-hydroxyphenyl)-1H-pyrazol-5...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 173 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330290 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 189 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330268 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 195 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330281 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 212 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330271 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 262 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330291 (1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 264 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330280 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 281 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330283 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 281 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330287 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 311 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 334 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 344 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330269 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 356 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330287 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 423 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330285 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 535 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330284 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 549 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330260 (1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 557 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330274 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 616 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330282 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 695 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330260 (1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 760 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM330286 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.42E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330261 (1-(3-(tert-butyl)-1-(4-hydroxyphenyl)-1H-pyrazol-5...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330286 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.54E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330286 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.54E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330289 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.58E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330289 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.58E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330282 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.59E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330283 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.59E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330280 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.59E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330280 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.59E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330288 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.62E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330287 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.62E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330290 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.62E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330288 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.62E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330290 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.62E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330284 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.63E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330284 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.63E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330281 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.66E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330281 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.66E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330279 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330260 (1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330279 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330265 (1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330285 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330291 (1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.38E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330261 (1-(3-(tert-butyl)-1-(4-hydroxyphenyl)-1H-pyrazol-5...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.49E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330260 (1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330265 (1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.74E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330262 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330264 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.51E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330264 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.51E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330266 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.55E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330266 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.55E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330276 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.58E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330276 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.58E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330278 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330278 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330274 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.62E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330271 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.62E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330264 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.62E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330264 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.62E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330274 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.62E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330271 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.62E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330263 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.63E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330268 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.63E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330275 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.63E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330272 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.63E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330272 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.63E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330268 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.63E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330263 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.63E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330275 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.63E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330273 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.66E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330262 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.66E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330273 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.66E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330270 (1-(3-(tert-butyl)-1-(p-tolyl)-lH-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330269 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM330269 (1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM330270 (1-(3-(tert-butyl)-1-(p-tolyl)-lH-pyrazol-5-yl)- 3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase 12 (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Tyrosine-protein kinase HCK (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Tyrosine-protein kinase HCK (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that descr... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Glycogen synthase kinase-3 (Homo sapiens (Human)) | BDBM161376 (US10238658, Example 1 | US9108950, 1 | US9724347, ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The GSK3-α protein (500 ng/mL, 2.5 μL) was mixed with the test compound (2.5 μL at either 4 μg/mL, 0.4 μg/mL, 0.04 μg/m... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| 5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM142598 (US10238658, Example Reference | US8933228, Ref 2 |...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a |
Respivert Ltd US Patent | Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the lev... | US Patent US9724347 (2017) BindingDB Entry DOI: 10.7270/Q2MC923K | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
